Avalon Investment & Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,109
| Closed | -$248K | – | 339 |
|
|
2020
Q3 | $248K | Sell |
3,109
-227
| -7% | -$18.1K | 0.01% | 306 |
|
|
2020
Q2 | $231K | Sell |
3,336
-1,638
| -33% | -$113K | 0.01% | 282 |
|
|
2020
Q1 | $313K | Sell |
4,974
-214,815
| -98% | -$13.5M | 0.01% | 276 |
|
|
2019
Q4 | $17.1M | Sell |
219,789
-12,783
| -5% | -$994K | 0.35% | 86 |
|
|
2019
Q3 | $17M | Sell |
232,572
-19,470
| -8% | -$1.43M | 0.38% | 88 |
|
|
2019
Q2 | $15.5M | Sell |
252,042
-27,726
| -10% | -$1.71M | 0.34% | 100 |
|
|
2019
Q1 | $17.8M | Sell |
279,768
-471
| -0.2% | -$30K | 0.41% | 79 |
|
|
2018
Q4 | $14.3M | Buy |
280,239
+11,085
| +4% | +$566K | 0.37% | 79 |
|
|
2018
Q3 | $15.6M | Sell |
269,154
-1,545
| -0.6% | -$89.7K | 0.44% | 75 |
|
|
2018
Q2 | $13.1M | Sell |
270,699
-5,079
| -2% | -$246K | 0.39% | 92 |
|
|
2018
Q1 | $12.8M | Buy |
+275,778
| New | +$12.8M | 0.4% | 94 |
|